Mobile

A Randomized, Open Label, Phase II Study of OSI-7904L versus 5-FU/LV as First-Line Treatment in Patients with Unresectable, Locally Advanced or Metastatic Adenocarcinoma of the Biliary Tract

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001155-11

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the objective response rates in patients with untreated unresectable, locally advanced or metastatic cancer of the biliary tract who are treated with OSI-7904L or 5-FU/LV.

Critère d'inclusion

  • Unresectable, locally advanced or metastatic adenocarcinoma of the biliary tract

Liens